Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14(10):101174.

Article  PubMed  PubMed Central  Google Scholar 

Morgan E, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338–44.

Article  PubMed  Google Scholar 

Hofseth LJ, et al. Early-onset colorectal cancer: initial clues and current views. Nat Rev Gastroenterol Hepatol. 2020;17(6):352–64.

Article  PubMed  PubMed Central  Google Scholar 

Van Cutsem E, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386–422.

Article  PubMed  Google Scholar 

Modest DP, et al. Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group. Ann Oncol. 2016;27(9):1746–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karapetis CS, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008;359(17):1757–65.

Article  CAS  PubMed  Google Scholar 

Amado RG, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26(10):1626–34.

Article  CAS  PubMed  Google Scholar 

Cervantes A, et al. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(1):10–32.

Article  CAS  PubMed  Google Scholar 

Wang W, et al. Prediction of KRAS gene mutations in colorectal cancer using a CT-based radiomic model. Front Med (Lausanne). 2025;12:1592497.

Article  PubMed  PubMed Central  Google Scholar 

Vuijk FA, et al. Intra-tumoral genomic heterogeneity in rectal cancer: mutational status is dependent on preoperative biopsy depth and location. Cancers (Basel). 2021. https://doi.org/10.3390/cancers13092271.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, et al. Characterization of cancer genomic heterogeneity by next-generation sequencing advances precision medicine in cancer treatment. Precis Clin Med. 2018;1(1):29–48.

Article  PubMed  PubMed Central  Google Scholar 

Kumar V, et al. Radiomics: the process and the challenges. Magn Reson Imaging. 2012;30(9):1234–48.

Article  PubMed  PubMed Central  Google Scholar 

Rizzo S, et al. Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp. 2018;2(1):36.

Article  PubMed  PubMed Central  Google Scholar 

Tomaszewski MR, Gillies RJ. The biological meaning of radiomic features. Radiology. 2021;298(3):505–16.

Article  PubMed  PubMed Central  Google Scholar 

Aerts H, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yip SS, Aerts HJ. Applications and limitations of radiomics. Phys Med Biol. 2016;61(13):R150–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia L-L, et al. Current status and quality of radiomic studies for predicting KRAS mutations in colorectal cancer patients: a systematic review and meta-analysis. Eur J Radiol. 2022;158:110640.

Article  PubMed  Google Scholar 

Mohammadpour S, et al. Image analysis as tool for predicting colorectal cancer molecular alterations: a scoping review. Mol Imaging Radionucl Ther. 2025;34(1):10.

Article  PubMed  PubMed Central  Google Scholar 

Shi R, et al. Prediction of KRAS, NRAS and BRAF status in colorectal cancer patients with liver metastasis using a deep artificial neural network based on radiomics and semantic features. Am J Cancer Res. 2020;10(12):4513.

CAS  PubMed  PubMed Central  Google Scholar 

Normanno N, et al. Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial. Ann Oncol. 2015;26(8):1710–4.

Article  CAS  PubMed  Google Scholar 

Jia L-L, et al. Current status and quality of radiomic studies for predicting KRAS mutations in colorectal cancer patients: a systematic review and meta‑analysis. Eur J Radiol. 2023;158:110640.

Article  PubMed  Google Scholar 

Russo M, et al. Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer. Cancer Discov. 2016;6(2):147–53.

Article  CAS  PubMed  Google Scholar 

Zheng X, et al. Diagnostic accuracy of deep learning and radiomics in lung cancer staging: a systematic review and meta-analysis. Front Public Health. 2022;10:938113.

Article  PubMed  PubMed Central  Google Scholar 

Inchingolo R, et al. Radiomics in colorectal cancer patients. World J Gastroenterol. 2023;29(19):2888.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng T, et al. Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer. Cancer Imaging. 2024;24(1):31.

Article  PubMed  PubMed Central  Google Scholar 

Ma T, et al. A machine learning-based radiomics model for prediction of tumor mutation burden in gastric cancer. Front Genet. 2023;14:1283090.

Article  PubMed  PubMed Central  Google Scholar 

Sohn B, et al. Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant. J Neurooncol. 2021;155(3):267–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fuster-Matanzo A, et al. Prediction of oncogene mutation status in non-small cell lung cancer leveraging radiomics from CT scans: a systematic review and meta-analysis with a special focus on artificial-intelligence-based methods. J Clin Oncol. 2024;42(16_suppl):e20603–e20603.

Article  Google Scholar 

Ali MA, et al. Predictive role of [18F] FDG PET-CT radiomic parameters for KRAS/BRAF/EGFR mutations in metastatic colorectal cancer patients. EJNMMI Rep. 2024;8(1):42.

Article  PubMed  PubMed Central  Google Scholar 

Kim S-J, Pak K, Kim K. Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis. Abdominal Radiology. 2019;44(5):1703–11.

Article  PubMed  Google Scholar 

Bleker J, et al. Single-center versus multi-center biparametric MRI radiomics approach for clinically significant peripheral zone prostate cancer. Insights Imaging. 2021;12(1):150.

Article  PubMed  PubMed Central  Google Scholar 

Chen B-Y, et al. MRI-based radiomics features to predict treatment response to neoadjuvant chemotherapy in locally advanced rectal cancer: a single center, prospective study. Front Oncol. 2022;12:801743.

Article  PubMed  PubMed Central